Investors
Presentations & Events
Presentations & Events
Upcoming Events
More events are coming soon.
Archived Events & Presentations
Sep
09
2024
at 7:00 AM EDT
H.C. Wainwright 26th Annual Global Investment Conference
Aug
14
2024
at 4:30 PM EDT
Second Quarter 2024 Earnings
Jun
01
2024
at 9:00 AM CDT
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
Title: |
A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of fadraciclib, an oral CDK2/9 inhibitor, in patients with advanced solid tumors and lymphoma |
Abstract No. for Publication: |
3125 |
Session Title: |
Poster Session – Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology |
May
14
2024
at 4:30 PM EDT
First Quarter 2024 Earnings
Mar
19
2024
at 4:30 PM EDT
Fourth Quarter 2022 Financial Results
Jan
08
2024
at 2:00 PM EST
Biotech Showcase
Nov
13
2023
at 4:30 PM EST
Third Quarter 2023 Earnings
Aug
09
2023
at 4:30 PM EDT
Second Quarter 2023 Earnings
May
11
2023
at 4:30 PM EDT
First Quarter 2023 Earnings
Mar
13
2023
at 3:00 PM PDT
35th Annual Roth Conference
Mar
13
2023
at 10:00 AM EDT
Oppenheimer 33rd Annual Healthcare Conference
Mar
06
2023
at 4:30 PM EST
Fourth Quarter 2022 Financial Results
Jan
10
2023
at 9:30 AM PST
Biotech Showcase
View our progress update delivered live on January 10th.
Jan
09
2023
LifeSci Partners Corporate Access Event
Nov
09
2022
at 4:30 PM EST
Third Quarter 2022 Financial Results
Oct
31
2022
at 10:00 AM EDT
Cyclacel Hosting Research & Development Day
Aug
10
2022
at 4:30 PM EDT
Second Quarter 2022 Financial Results
May
11
2022
at 4:30 PM EDT
First Quarter 2022 Financial Results
Mar
28
2022
at 4:30 PM EDT
Fourth Quarter 2021 Financial Results